ADAR1 Capital Management’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
ADAR1 Capital Management's ORKA Position: Q3 2026 in Review
ADAR1 Capital Management sold out of Oruka Therapeutics (ORKA) in Q3 2026, closing a stake of 20,840 shares — an estimated $1.98M sold.
ADAR1 Capital Management first reported a position in ORKA in Q2 2024 and held it in 8 quarters. The position peaked at $1.98M in Q2 2026. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.
- ADAR1 Capital Management reported no remaining Oruka Therapeutics position as of Q3 2026 after selling out during the quarter.
- ADAR1 Capital Management sold 20,840 Oruka Therapeutics shares in Q3 2026, an estimated $1.98M.
- ADAR1 Capital Management first reported a position in Oruka Therapeutics in Q2 2024 and held it in 8 quarters.
- ADAR1 Capital Management's Oruka Therapeutics position peaked at $1.98M in Q2 2026.
- 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.
Based on ADAR1 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.